If some variants are reported as potentially germline, then the report must contain a statement indicating that the germline status cannot be asserted with certainty, even if all evidence points towards a germline origin (e.g., a TP53 variant with a VAF of 50% in a sample with very little tumor content). The gene discussed is TP53; the disease is neoplasm.